IL1B and Alzheimer disease: In turn, reductions in NF-κβ-regulated genes, such as Il-1β, Cox2 and Tnf-α, were observed after treatments with selective I2-IR ligands, delivering neuroprotection in mouse models of aging neurodegeneration and AD [14,15,16,39].